These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 18156462)
1. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats. Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Imazeki I; Kusano E; Shigematsu T; Akizawa T Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462 [TBL] [Abstract][Full Text] [Related]
2. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. Shiizaki K; Negi S; Hatamura I; Sakaguchi T; Saji F; Kunimoto K; Mizobuchi M; Imazeki I; Ooshima A; Akizawa T J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509 [TBL] [Abstract][Full Text] [Related]
3. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency. Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M Nephrol Dial Transplant; 2006 Mar; 21(3):634-43. PubMed ID: 16169864 [TBL] [Abstract][Full Text] [Related]
4. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection. Shiizaki K; Hatamura I; Nakazawa E; Ogura M; Masuda T; Akizawa T; Kusano E Med Mol Morphol; 2008 Jun; 41(2):76-82. PubMed ID: 18592161 [TBL] [Abstract][Full Text] [Related]
5. Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells. Shiizaki K; Negi S; Hatamura I; Tatsuta K; Shibata M; Shimada S; Sakaguchi T; Akizawa T Kidney Int Suppl; 2006 Jul; (102):S12-5. PubMed ID: 16810304 [TBL] [Abstract][Full Text] [Related]
6. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism. Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Kunimoto K; Okamoto M; Imazeki I; Muragaki Y; Akizawa T Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697 [TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
8. Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells. Shiizaki K; Hayakawa N; Imazeki I; Hatamura I; Okada T; Negi S; Sakaguchi T; Shigematsu T; Akizawa T Nephrol Dial Transplant; 2007 Apr; 22(4):1078-86. PubMed ID: 17234669 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia. Shiizaki K; Hatamura I; Negi S; Narukawa N; Mizobuchi M; Sakaguchi T; Ooshima A; Akizawa T Kidney Int; 2003 Sep; 64(3):992-1003. PubMed ID: 12911549 [TBL] [Abstract][Full Text] [Related]
10. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism. Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622 [TBL] [Abstract][Full Text] [Related]
11. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors. Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139 [TBL] [Abstract][Full Text] [Related]
12. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism. Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002 [TBL] [Abstract][Full Text] [Related]
13. Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia. Shiizaki K; Fukagawa M; Yuan Q; Hatamura I; Nii-Kono T; Saji F; Shigematsu T; Akizawa T Am J Nephrol; 2008; 28(1):59-66. PubMed ID: 17901691 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats. Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L; Anast CS; Forte LR Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783 [TBL] [Abstract][Full Text] [Related]
16. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients. Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419 [TBL] [Abstract][Full Text] [Related]
17. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627 [TBL] [Abstract][Full Text] [Related]
18. [Basic and clinical aspects of calcimimetics. Effect of direct injection therapy in the expression of calcium-sensing receptor in parathyroid cell]. Shiizaki K; Tozawa R; Kusano E Clin Calcium; 2008 Jan; 18(1):51-6. PubMed ID: 18175872 [TBL] [Abstract][Full Text] [Related]
19. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease. Arcidiacono MV; Yang J; Fernandez E; Dusso A Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism. Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]